Primary lymphedema of childhood: Treatment results from a tertiary center

Basit Öğe Kaydı
dc.authoridcinar, ece/0000-0002-9710-1582
dc.authoridATA, BENIL NESLI/0000-0003-0900-0069
dc.contributor.authorCinar, Ece
dc.contributor.authorAta, Benil Nesli
dc.contributor.authorEyigor, Sibel
dc.date.accessioned2025-03-20T09:51:11Z
dc.date.available2025-03-20T09:51:11Z
dc.date.issued2024
dc.departmentİzmir Bakırçay Üniversitesi
dc.description.abstractBackground: Primary lymphedema is the most common form of lymphedema presenting in the pediatric age group. Childhood lymphedema is caused by hereditary or congenital malformations in the lymphatic system that can manifest at birth or during childhood or adolescence. Objectives: Complex decongestive therapy (CDT) is the cornerstone of conservative management of lymphedema in both adult and pediatric lymphedema patients, although pediatric treatment guidelines are still lacking. In this study we aimed to assess the effects of CDT on pediatric patients. Methods: Childhood lymphedema patients who presented to the lymphedema rehabilitation unit of our university hospital before the age of 18 and who were treated for lymphedema with CDT were included in the study. Data on patient demographics, disease characteristics, and treatment duration were recorded. Limb volumes were calculated from patient measurements using a spreadsheet software (Limb Volume Calculator) that utilized the geometric formula for volume of a truncated cone. Measurements were taken before treatment and also weekly after initiation of treatment. Percent excess volume (PEV) was used instead of absolute volume difference to define the severity of lymphedema. Results: A total of 34 limbs from 24 patients were included in the study. The mean age of the patients was 10.1 +/- 4.9 years and 14 (58.3 %) were female. Most patients had one affected limb but 16 had bilateral lowerextremity lymphedema. The mean duration of treatment with CDT was 153.6 +/- 155.8 days. Excess volume percentage change between pre-treatment PEV (602.8 +/- 713.8) and post-treatment PEV (514.6 +/- 699.1) was found to be statistically significant (p < 0.05). Conclusion: Pediatric lymphedema management is a difficult and less well studied area in lymphedema rehabilitation. Our data support the use of CDT, which is a safe and effective treatment method, for pediatric lymphedema patients.
dc.identifier.doi10.1016/j.arcped.2024.02.002
dc.identifier.endpage249
dc.identifier.issn0929-693X
dc.identifier.issn1769-664X
dc.identifier.issue4
dc.identifier.pmid38637245
dc.identifier.scopusqualityQ2
dc.identifier.startpage245
dc.identifier.urihttps://doi.org/10.1016/j.arcped.2024.02.002
dc.identifier.urihttps://hdl.handle.net/20.500.14034/2461
dc.identifier.volume31
dc.identifier.wosWOS:001243523100001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier France-Editions Scientifiques Medicales Elsevier
dc.relation.ispartofArchives De Pediatrie
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WOS_20250319
dc.subjectComplex decongestive therapy
dc.subjectLymphedema
dc.subjectPediatric lymphedema
dc.subjectRehabilitation
dc.titlePrimary lymphedema of childhood: Treatment results from a tertiary center
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu